Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of methotrexate/dexamethasone combination on epithelial-mesenchymal transition and inflammation gene expression of human RPE cells in-vitro. | Front Pharmacol | 2025 | 40371355 | PubTator, text mining | PubMed |
| Prognostic and diagnostic value of PVR gene and protein levels, serum amylase, and urinary IGFBP-7 and TIMP-2 biomarkers in multiple myeloma. | BMC Cancer | 2025 | 40369504 | PubTator, text mining | PubMed |
| Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning. | J Extracell Vesicles | 2025 | 40366616 | PubTator, text mining | PubMed |
| Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families. | Front Immunol | 2025 | 40356928 | PubTator, text mining | PubMed |
| Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: Focusing on the primitive enterocyte phenotype and PVR. | Br J Cancer | 2025 | 40341250 | PubTator, text mining | PubMed |
| Immunomodulatory effects of dental pulp stem cells on lymphocytes and monocytes from patients with rheumatoid arthritis. | Clin Exp Rheumatol | 2025 | 40338061 | PubTator, text mining | PubMed |
| The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer. | Cancer Res | 2025 | 40327600 | PubTator, text mining | PubMed |
| Potential Roles of Serum Exosomal CD155 and its Impact on NK Cell Immunosuppression in Hepatocellular Carcinoma. | Balkan Med J | 2025 | 40326845 | PubTator, text mining | PubMed |
| Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells. | Proc Natl Acad Sci U S A | 2025 | 40324075 | PubTator, text mining | PubMed |
| Agarose Microgel-Based In Situ Cleavable Immuno-Rolling Circle Amplification for Multiplexed Single-Molecule Quantitation on Single Extracellular Vesicles. | ACS Nano | 2025 | 40320637 | PubTator, text mining | PubMed |
| GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout. | Cancer Immunol Immunother | 2025 | 40317320 | PubTator, text mining | PubMed |
| CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection. | Int J Clin Oncol | 2025 | 40287900 | PubTator, text mining | PubMed |
| Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells. | Cancer Immunol Immunother | 2025 | 40274631 | PubTator, text mining | PubMed |
| Promising New Anti-TIGIT Agents: Stealthy Allies in Cancer Immunotherapy. | Clin Transl Sci | 2025 | 40261799 | PubTator, text mining | PubMed |
| The Significance of Nectin Family Proteins in Various Cancerogenous Processes. | Int J Mol Sci | 2025 | 40244005 | PubTator, text mining | PubMed |
| Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies. | Invest New Drugs | 2025 | 40232354 | PubTator, text mining | PubMed |
| Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-γ-p-STAT1-IRF8 axis in cancer therapy. | Cell Death Differ | 2025 | 40229462 | PubTator, text mining | PubMed |
| Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis. | Cell Mol Biol Lett | 2025 | 40217455 | PubTator, text mining | PubMed |
| Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor. | J Biol Chem | 2025 | 40216247 | PubTator, text mining | PubMed |
| Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy. | Front Immunol | 2025 | 40196117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=16